Diagnosis, management, and treatment of
Alzheimer disease: a guide for the internist

by
Richards SS, Hendrie HC
Department of Psychiatry,
Indiana University School of Medicine,
Indianapolis 46202-5111, USA.
Arch Intern Med 1999 Apr 26; 159(8):789-98


ABSTRACT

Alzheimer disease (AD) is a diagnosis of inclusion based on patient history, physical examination, neuropsychological testing, and laboratory studies; however, there is no definitive diagnostic test for AD. Early recognition of AD allows time to plan for the future and to treat patients before marked deterioration occurs. Effective treatment requires monitoring of symptoms, functional impairment, and safety, and the use of multiple treatment modalities including pharmacotherapy, behavioral management, psychotherapies, psychosocial treatments, and support and education for families. Pharmacotherapeutic agents available for AD only provide symptomatic relief. The cholinesterase inhibitors, tacrine and donepezil, are effective in improving cognition, delaying nursing home placement, and improving behavioral complications in some patients. Other cholinesterase inhibitors are in development, as are other cholinomimetic agents such as muscarinic and nicotinic receptor agonists. Symptomatic treatments are available for the psychiatric manifestations of AD. Anti-inflammatories, antioxidants, neurotrophic factors, and other agents are promising new treatments for the future.
Tacrine
Memory
Adrafinil
Selegiline
Donepezil
Aniracetam
Galantamine
Rivastigmine
Ginkgo biloba
Medicinal plants
Alzheimer's disease
Cholinesterase inhibitors
Alzheimer's disease: hotlinks
Selegiline and Alzheimer's disease

Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family